Promoting Healthy Skepticism In The News: Helping Journalists Get It Right

Main Category: Cancer / Oncology
Article Date: 22 Nov 2009 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:4 stars

4 (1 votes)


An editorial published online November 20 in the Journal of the National Cancer Institute discusses the exaggerated fears and hopes that often appear in news coverage of cancer research. The editorial provides guidance for both the media and journals to help alleviate the problem.

Lisa M. Schwartz, M.D., M.S., and Steven Woloshin, M.D., M.S., of Center for Medicine and the Media at the Dartmouth Institute for Health Policy and Clinical Practice in New Hampshire, and Barnett S. Kramer, M.D., editor-in-chief of the JNCI, use recent media coverage of two studies from the New England Journal of Medicine and the JNCI to demonstrate their point.

Coverage of trial results of the new anti-cancer drug olaparib, which appeared in the NEJM, exaggerated hope in many ways. One national news outlet claimed the drug "was the most important cancer breakthrough of the decade," but failed to note that the study was uncontrolled (so there is no way to know if the drug accounted for the findings), and very preliminary (it is not known if the findings will ever translate into longer life).

The editorialists also point to coverage of a JNCI article on alcohol consumption and cancer risk among women, which may have caused unwarranted fear: "A drink a day raises women's risk of cancer," read one newspaper headline. Unfortunately, the coverage did not provide the magnitude of the risk. Comparing the highest level of drinking (≥15 drinks a week) to the lowest (one to two drinks per week), the investigators observed a 0.6% absolute increase in the risk of breast cancer diagnosis: from 2% to 2.6% for more than 7 years.

Journalists are not the only ones to blame, though, according to the editorialists. Medical journals sometimes leave important elements out of studies. In many cases, absolute risks and study limitations are omitted from the abstracts and journal press releases.

To help journalists and medical journals, the editorialists include tip sheets with guidance on questions to ask study authors, the interpretation of common statistics, and ways to highlight study limitations.

The tip sheets are posted on a new JNCI Web site for science writers: see here.

"We hope that efforts-within medical journals and those directed toward journalists-will help foster healthy skepticism in the news," the authors write. "Namely, setting a higher bar for covering very preliminary or inherently weak research, routinely providing data to support claims, and always highlighting study limitations."

Source
The Journal of the National Cancer Institute

Article adapted by Medical News Today from original press release.
Visit our cancer / oncology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
The Journal of the National Cancer Institute. "Promoting Healthy Skepticism In The News: Helping Journalists Get It Right." Medical News Today. MediLexicon, Intl., 22 Nov. 2009. Web.
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/171749.php>

APA
The Journal of the National Cancer Institute. (2009, November 22). "Promoting Healthy Skepticism In The News: Helping Journalists Get It Right." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/171749.php.

Please note: If no author information is provided, the source is cited instead.


Cancer / Oncology

What is Cancer?

Cancer is a class of diseases characterized by out-of-control cell growth. There are over 100 different types of cancer, and each is classified by the type of cell that is initially affected. Read more...

Most Popular Articles



Follow Our Cancer News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cancer / Oncology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »